Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens | PLOS ONE
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Ritonavir Increases levels of Schering HCV Protease Inhibitor SCH503034
Ritonavir - Wikipedia
Ritonavir boosting of low-dose danoprevir (RG7227; ITMN-191), HCV NS3/4A protease inhibitor, results in robust reduction in HCV RNA at lower exposures than provided by unboosted regimens
Structures of the boosters (CYP inhibitors) ritonavir and cobicistat,... | Download Scientific Diagram
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study - The Lancet HIV
What Is Lopinavir and Ritonavir Combination Therapy?
Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing's syndrome - S Noe, H Jaeger, S Heldwein, 2018
Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients. | Semantic Scholar
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir ... | GrepMed
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment | Scientific Reports
Summary of unboosted and ritonavir-boosted PI dose regimens | Download Table
Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
Lopinavir/ritonavir - Wikipedia
Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression - ScienceDirect
How Ritonavir acts as booster drug - YouTube
The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins - ScienceDirect
Ritonavir | C37H48N6O5S2 | CID 392622 - PubChem
Ritonavir 155213-67-5 | TCI AMERICA
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial - The Lancet HIV
How Ritonavir acts as booster drug - YouTube
HIV-Protease Inhibitors: Viral Resistance, Pharmacokinetic Boosting, and Medication Adherence
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
